Vaz-Pereira, S
Collaço, L
De Salvo, G
van Zeller, P
Article History
First Online: 4 March 2016
Competing interests
: Dr SVP has received consultant fees from Bayer and Novartis and has received travel grants from Bayer, Novartis, Alcon, Allergan and Alimera Sciences. Dr LC has received travel grants from Bayer. Dr GDS has received travel grants from Bayer and Heidelberg Engineering. The remaining author declares no conflict of interest.